BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bahreyni A, Mohamud Y, Luo H. Emerging nanomedicines for effective breast cancer immunotherapy. J Nanobiotechnology 2020;18:180. [PMID: 33298099 DOI: 10.1186/s12951-020-00741-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Vijaya Bharathi S, Das M. Cytotoxicity effect of nanoparticles of Euphorbia antiquorum on breast cancer cell line. South African Journal of Botany 2022;151:410-416. [DOI: 10.1016/j.sajb.2022.10.017] [Reference Citation Analysis]
2 Cafora M, Poerio N, Forti F, Loberto N, Pin D, Bassi R, Aureli M, Briani F, Pistocchi A, Fraziano M. Evaluation of phages and liposomes as combination therapy to counteract Pseudomonas aeruginosa infection in wild-type and CFTR-null models. Front Microbiol 2022;13:979610. [DOI: 10.3389/fmicb.2022.979610] [Reference Citation Analysis]
3 Rethi L, Mutalik C, Anurogo D, Lu L, Chu H, Yougbaré S, Kuo T, Cheng T, Chen F. Lipid-Based Nanomaterials for Drug Delivery Systems in Breast Cancer Therapy. Nanomaterials 2022;12:2948. [DOI: 10.3390/nano12172948] [Reference Citation Analysis]
4 Bahreyni A, Liu H, Mohamud Y, Xue YC, Zhang J, Luo H. A new miRNA-Modified coxsackievirus B3 inhibits triple negative breast cancer growth with improved safety profile in immunocompetent mice. Cancer Lett 2022;:215849. [PMID: 35995138 DOI: 10.1016/j.canlet.2022.215849] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Senigagliesi B, Samperi G, Cefarin N, Gneo L, Petrosino S, Apollonio M, Caponnetto F, Sgarra R, Collavin L, Cesselli D, Casalis L, Parisse P. Triple negative breast cancer-derived small extracellular vesicles as modulator of biomechanics in target cells. Nanomedicine 2022;44:102582. [PMID: 35817390 DOI: 10.1016/j.nano.2022.102582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rodríguez-Izquierdo I, Sepúlveda-Crespo D, Lasso JM, Resino S, Muñoz-Fernández MÁ. Baseline and time-updated factors in preclinical development of anionic dendrimers as successful anti-HIV-1 vaginal microbicides. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2022;14:e1774. [PMID: 35018739 DOI: 10.1002/wnan.1774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Gowd V, Ahmad A, Tarique M, Suhail M, Zughaibi TA, Tabrez S, Khan R. Advancement of cancer immunotherapy using nanoparticles-based nanomedicine. Seminars in Cancer Biology 2022. [DOI: 10.1016/j.semcancer.2022.03.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
8 Xu J, Su Z, Cheng X, Hu S, Wang W, Zou T, Zhou X, Song Z, Xia Y, Gao Y, Zheng Q. High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma. Cancer Cell Int 2022;22. [DOI: 10.1186/s12935-022-02508-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Tagde P, Najda A, Nagpal K, Kulkarni GT, Shah M, Ullah O, Balant S, Rahman MH. Nanomedicine-Based Delivery Strategies for Breast Cancer Treatment and Management. IJMS 2022;23:2856. [DOI: 10.3390/ijms23052856] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Senigagliesi B, Samperi G, Cefarin N, Gneo L, Petrosino S, Apollonio M, Caponnetto F, Sgarra R, Collavin L, Cesselli D, Casalis L, Parisse P. Triple Negative Breast Cancer-derived Small Extracellular Vesicles as Modulator of Biomechanics in target cells.. [DOI: 10.1101/2022.02.28.481921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Singh P, Yadav M, Niveria K, Verma AK. Nano-immunotherapeutics: targeting approach as strategic regulation at tumor microenvironment for cancer treatment. Exploration of Medicine. [DOI: 10.37349/emed.2022.00072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ding M, Zhang Y, Li J, Pu K. Bioenzyme-based nanomedicines for enhanced cancer therapy. Nano Converg 2022;9:7. [PMID: 35119544 DOI: 10.1186/s40580-022-00297-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Rathi MA, Girisan EK, Gopalakrishnan VK, Meenakshi P, Guru Kumar D. Nanomaterials as Drug Carriers in Diagnosis and Treatment of Various Cancers. Materials Horizons: From Nature to Nanomaterials 2022. [DOI: 10.1007/978-981-19-2639-6_11] [Reference Citation Analysis]
14 Mi X, Xu XY, Choi HS, Kim H, Cho I, Yi T, Kim Y. The Immune-Enhancing Properties of Hwanglyeonhaedok-Tang-Mediated Biosynthesized Gold Nanoparticles in Macrophages and Splenocytes. IJN 2022;Volume 17:477-94. [DOI: 10.2147/ijn.s338334] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Jamil A, Geso M, Algethami M, Wan Sohaimi WF, Abdul Razak K, Rahman WN. The effect of polyvinylpyrrolidone-coated (PVP) on bismuth-based nanoparticles cell cytotoxicity. Materials Today: Proceedings 2022;66:2948-2951. [DOI: 10.1016/j.matpr.2022.06.564] [Reference Citation Analysis]
16 Zhu M, Shi Y, Shan Y, Guo J, Song X, Wu Y, Wu M, Lu Y, Chen W, Xu X, Tang L. Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics. J Nanobiotechnology 2021;19:387. [PMID: 34819084 DOI: 10.1186/s12951-021-01131-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 9.0] [Reference Citation Analysis]
17 Zhou Z, Jiang N, Chen J, Zheng C, Guo Y, Ye R, Qi R, Shen J. Selectively down-regulated PD-L1 by albumin-phenformin nanoparticles mediated mitochondrial dysfunction to stimulate tumor-specific immunological response for enhanced mild-temperature photothermal efficacy. J Nanobiotechnology 2021;19:375. [PMID: 34794446 DOI: 10.1186/s12951-021-01124-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
18 Xu J, Zheng Q, Cheng X, Hu S, Zhang C, Zhou X, Sun P, Wang W, Su Z, Zou T, Song Z, Xia Y, Yi X, Gao Y. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma. J Nanobiotechnology 2021;19:355. [PMID: 34717654 DOI: 10.1186/s12951-021-01101-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
19 Herdiana Y, Wathoni N, Shamsuddin S, Muchtaridi M. α-Mangostin Nanoparticles Cytotoxicity and Cell Death Modalities in Breast Cancer Cell Lines. Molecules 2021;26:5119. [PMID: 34500560 DOI: 10.3390/molecules26175119] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Ye J, Li R, Yang Y, Dong W, Wang Y, Wang H, Sun T, Li L, Shen Q, Qin C, Xu X, Liao H, Jin Y, Xia X, Liu Y. Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations. J Nanobiotechnology 2021;19:199. [PMID: 34225762 DOI: 10.1186/s12951-021-00946-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Akkın S, Varan G, Bilensoy E. A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers. Molecules 2021;26:3382. [PMID: 34205019 DOI: 10.3390/molecules26113382] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 19.0] [Reference Citation Analysis]
22 Zhao Y, Xiao W, Peng W, Huang Q, Wu K, Evans CE, Liu X, Jin H. Oridonin-Loaded Nanoparticles Inhibit Breast Cancer Progression Through Regulation of ROS-Related Nrf2 Signaling Pathway. Front Bioeng Biotechnol 2021;9:600579. [PMID: 33898397 DOI: 10.3389/fbioe.2021.600579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]